Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

3

SEC Filing Details

Document Details

Form
Filing Date
Dec 11, 2020
Document Date
Dec 5, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Wave Life Sciences
Issuer
Wave Life Sciences Ltd.
Filer
Moran Kyle